Who is sponsoring NCT03674840?

NCT03674840 is sponsored by Peking University Third Hospital.

What drugs are being tested in NCT03674840?

Interventions in NCT03674840: angle kappa based SBL-3 implantation, 0 to 180 degree SBL-3 implantation.

What condition does NCT03674840 study?

NCT03674840 studies Cataract, Age-Related.

Is NCT03674840 still recruiting?

NCT03674840 is currently completed. Last updated 5 August 2022.

Last reviewed 2022-08-05 · How we verify

NCT03674840

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Optical Quality With Different Placement of Refractive Multifocal Intraocular Lens

Completed NA Last updated 5 August 2022

What this trial tests

NA trial testing angle kappa based SBL-3 implantation in Cataract, Age-Related in 40 participants. Completed in 1 April 2019.

Timeline

12 June 2017

Primary endpoint
1 February 2019

1 April 2019

Quick facts

Lead sponsor	Peking University Third Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	40
Start date	12 June 2017
Primary completion	1 February 2019
Estimated completion	1 April 2019
Sites	1 location across China

Drugs / interventions tested

angle kappa based SBL-3 implantation
0 to 180 degree SBL-3 implantation

Conditions studied

Cataract, Age-Related — all drugs for Cataract, Age-Related →

Sponsor

Peking University Third Hospital

Who can join

Adults 54 to 81, any sex, with Cataract, Age-Related. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to compare postoperative optical quality between two different implanting position of a rotationally asymmetric MIOL \[SBL-3 Lenstec; +3.00 diopters (D)\], angle kappa based implantation and 0 to 180 degree implantation, in order to find out the optimal implantation position for SBL-3.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Peking University Third Hospital trials

Trials by the same sponsor.

NCT07532421 — Probiotic Intervention on the Development of Allergic Diseases in Infants Exposed to Antibiotics Early in Life · NA · not yet recruiting
NCT07470255 — Detection of Diabetic Foot Skin Damage Using Plantar Mechanical Parameters · not yet recruiting
NCT07453381 — Multisensor Wireless Pressure Microcatheter For Microvascular Function Assessment In ANOCA/INOCA Patients: A Prospective · not yet recruiting
NCT07452354 — AI-Based Diabetic Foot Recurrence Cohort · not yet recruiting
NCT07423819 — Sports Rehabilitation Therapy for Knee Joint Sports Injuries: A Case Study of Anterior Cruciate Ligament Injury and Pate · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03674840 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Peking University Third Hospital
Last refreshed: 5 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03674840.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing